Affordable Access

deepdyve-link
Publisher Website

Pathogenic mutations cause rapid degradation of lysosomal storage disease-related membrane protein CLN6.

Authors
  • Kurze, Anna-Katherina
  • Galliciotti, Giovanna
  • Heine, Claudia
  • Mole, Sara E
  • Quitsch, Arne
  • Braulke, Thomas
Type
Published Article
Journal
Human Mutation
Publisher
Wiley (John Wiley & Sons)
Publication Date
Feb 01, 2010
Volume
31
Issue
2
Identifiers
DOI: 10.1002/humu.21184
PMID: 20020536
Source
Medline
License
Unknown

Abstract

One variant form of late infantile neuronal ceroid lipofuscinosis is an autosomal recessive inherited neurodegenerative lysosomal storage disorder caused by mutations in the CLN6gene. The function of the polytopic CLN6 membrane protein localized in the endoplasmic reticulum is unknown. Here we report on expression studies of three mutations (c.368G>A, c.460-462delATC, c.316insC) found in CLN6 patients predicted to affect transmembrane domain 3 (p.Gly123Asp), cytoplasmic loop 2 (p.Ile154del) or result in a truncated membrane protein (p.Arg106ProfsX26), respectively. The rate of synthesis and the stability of the mutant CLN6 proteins are reduced in a mutation-dependent manner. None of the mutations prevented the dimerization of the CLN6 polypeptides. The particularly rapid degradation of the p.Arg106ProfsX26 mutant which is identical with the mutation in the murine orthologue Cln6 gene in the nclf mouse model of the disease, can be strongly inhibited by proteasomal and partially by lysosomal protease inhibitors. Both degradative pathways seem to be sufficient to prevent the accumulation/aggregation of the mutant CLN6 polypeptides in the endoplasmic reticulum.

Report this publication

Statistics

Seen <100 times